
    
      This trial will be an placebo-controlled, two-centre, randomized control trial with two
      parallel groups including 1,162 women who undergo elective or emergency caesarean deliveries
      at term. The study group will receive tranexamic acid (TXA) 1g intravenously at the onset of
      skin incision. There is normal saline placebo for the control group. The study and control
      groups will both receive the standard care offered at caesarean section including 5 IU of
      oxytocin intravenously on delivery of the baby. .
    
  